logo
logo

BAIBYS raised $4.5M in a Series A led by Firstime Ventures to develop an AI-based system that selects ideal sperm for fertility treatments.

Aug 08, 2024•11 months ago

Amount Raised

$4.5 Million

Round Type

series a

Tel AvivBiotechnologyHealth Care

Investors

RohtoFirstime Ventures

Description

Israeli startup BAIBYS has completed its $4.5 million Series A funding round, which aims to enhance fertility treatment success rates through an autonomous sperm selection system. The round was led by Firstime Ventures, with participation from ROHTO, a Japanese pharmaceutical giant.

Company Information

Company

BAIBYS

Location

Tel Aviv, Tel Aviv District, Israel

About

BAIBYS' system is a complete and integrated solution for autonomous sperm selection. BAIBYS’ autonomous sperm selection solution for In-Vitro Fertilization (IVF) is designed to analyze living sperm cells in real-time using machine vision (MV) and artificial intelligence (AI). BAIBYS’ technology evaluates the sperm cells according to morphological criteria, which can only be identified using high magnification. The system recognizes structures in motion, to evaluate the quality of living sperm cells according to previously established criteria using proprietary AI algorithms. Utilizing robotics, BAIBYS’ system then autonomously selects and collects the sperm with the highest fertilization potential, ready to microinject into the egg in IVF procedures.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Related People